Compound Summary


ouabain
  Compound Information
 ouabain

Compound Name:

ouabain

Compound CID:

439501

Synonyms:

ouabain

G-Strophanthin

Ouabaine

Ouabagenin L-rhamnoside

Oubain

More...

Iupac Name:

3-[(1R,3S,5S,8R,9S,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one

InChI:

InChI=1S/C29H44O12/c1-13-22(34)23(35)24(36)25(40-13)41-15-8-19(32)28(12-30)21-17(3-5-27(28,37)9-15)29(38)6-4-16(14-7-20(33)39-11-14)26(29,2)10-18(21)31/h7,13,15-19,21-25,30-32,34-38H,3-6,8-12H2,1-2H3/t13-,15-,16+,17+,18+,19+,21+,22-,23+,24+,25-,26+,27-,28+,29-/m0/s1

InChIKey:

LPMXVESGRSUGHW-HBYQJFLCSA-N

Canonical Smiles:

CC1C(C(C(C(O1)OC2CC(C3(C4C(CCC3(C2)O)C5(CCC(C5(CC4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O

Isomeric Smiles:

C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2C[C@H]([C@@]3([C@@H]4[C@@H](CC[C@@]3(C2)O)[C@]5(CC[C@@H]([C@]5(C[C@H]4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O

Molecular Weight:

584.7

Molecular Formula:

C29H44O12

  Compound Structure
 2D Structure:
 3D Structure:
  Computed Properties
 ouabain

Molecular Weight:

584.7

Molecular Formula:

C29H44O12

Hydrogen Bond Donor Count:

8

Hydrogen Bond Acceptor Count:

12

Rotatable Bond Count:

4

Heavy Atom Count:

41

Complexity:

1080

  Synonyms
 ouabain

ouabain ouabain

ouabain

G-Strophanthin

Ouabaine

Ouabagenin L-rhamnoside

Oubain

Ouabain anhydrous

Acocantherin

Astrobain

Gratibain

Purostrophan

Ouabain octahydrate

630-60-4

Ouabagenin-L-rhamnosid

Strophalen

Kombetin

Strodival

Uabaina

Acocantherine

Gratus strophanthin

Rectobaina

Solufantina

Strophoperm

Strophosan

G-Strophicor

UNII-5ACL011P69

CHEBI:472805

Uabanin

MLS000069786

CHEMBL222863

Ouabain, Octahydrate

5ACL011P69

Quabain

SMR000058492

Strophanthin-G

DSSTox_CID_23765

DSSTox_RID_80072

DSSTox_GSID_43765

3-(alpha-L-rhamnopyranosyloxy)-1beta,5beta,11alpha,14,19-pentahydroxy-5beta-card-20(22)-enolide

Card-20(22)-enolide, 3-(6-deoxy-.alpha.-L-mannopyranosyl)oxy-1,5,11,14,19-pentahydroxy-, (1.beta.,3.beta.,5.beta.,11.alpha.)-

OBN

NSC-25485

Cardiac glycoside

4-(1S,2R,3R,5S,7S,10R,11S,14R,15R,17R)-3,7,11,17-tetrahydroxy-2-(hydroxymethyl)-15-methyl-5-{(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yloxy}tetracyclo8.7.0.0^{2,7}.0^{11,15}heptadecan-14-yl-2,5-dihydrofuran-2-one

CAS-630-60-4

Ouabagenin-L-rhamnosid German

G-Strophanthin (JAN)

SR-01000076047

CCRIS 965

HSDB 3519

1ibg

NCGC00163473-01

3-(1R,3S,5S,8R,9S,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yloxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopentaaphenanthren-17-yl-2H-furan-5-one

EINECS 211-139-3

NSC 25485

BRN 0101712

3a3y

Opera_ID_395

4-5-((6S,2R,3R,4R,5R)-3,4,5-trihydroxy-6-methyl(2H-3,4,5,6-tetrahydropyran-2- yloxy))(1S,5S,7S,11S,2R,3R,10R,14R,15R,17R)-3,7,11,17-tetrahydroxy-2-(hydroxym ethyl)-15-methyltetracyclo8.7.0.0<2,7>.0<

Prestwick0_000471

Prestwick1_000471

Prestwick2_000471

Prestwick3_000471

Epitope ID:161502

O 3125

Lopac0_000943

SCHEMBL15433

BSPBio_000602

5-18-05-00625 (Beilstein Handbook Reference)

Card-20(22)-enolide, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-1,5,11,14,19-pentahydroxy-, (1beta,3beta,5beta,11alpha)-

SPBio_002541

BPBio1_000664

cid_439501

GTPL4826

DTXSID0043765

REGID_for_CID_439501

3n23

HMS2089J19

HMS2235A07

HMS3262N08

ZINC8143614

Tox21_110024

Tox21_112057

Tox21_301547

Tox21_500943

BDBM50286739

AKOS024285581

Tox21_112057_1

CCG-205024

CCG-208243

DB01092

LP00943

SDCCGSBI-0050917.P002

3-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-1,5,11alpha,14,19-pentahydroxycard-20(22)-enolide

3-(6-Deoxy-alpha-L-mannopyranosyloxy)-1,5,11a,14,19-pentahydroxycard-20(22)-enolide

SMP1_000142

NCGC00013319-01

NCGC00015769-17

NCGC00015769-32

NCGC00017394-02

NCGC00017394-07

NCGC00017394-11

NCGC00255970-01

NCGC00261628-01

NCGC00263656-01

ST085767

EU-0100943

C01443

D00112

11,15>heptadec-14-yl-5-hydrofuran- 2-one

Q285911

SR-01000721848

SR-01000076047-1

SR-01000076047-5

SR-01000721848-2

SR-01000721848-4

BRD-K35708212-331-03-1

(1alpha,3beta,5beta,11alpha,17alpha)-3-(6-deoxy-alpha-L-mannopyranosyl)oxy-1,5,11,14,19-pentahydroxycard-20(22)-enolide

3-(6-Deoxy-.alpha.-L-mannopyranosyl)oxy-1,5,11.alpha.,14,19-pentahydroxycard-20(22)-enolide

4-((1R,3S,5S,8R,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-2H-pyran-2-yloxy)-hexadecahydro-1H-cyclopentaaphenanthren-17-yl)furan-2(5H)-one

4-((1R,3S,5S,8R,9S,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)hexadecahydro-1H-cyclopentaaphenanthren-17-yl)furan-2(5H)-one

4-((1R,3S,5S,8R,9S,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-2H-pyran-2-yloxy)-hexadecahydro-1H-cyclopentaaphenanthren-17-yl)furan-2(5H)-one

4-((1R,3S,5S,9S,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)hexadecahydro-1H-cyclopentaaphenanthren-17-yl)furan-2(5H)-one

4-(1R,3S,5S,10R,11R,13R,14S,17R)-1,5,11,14-Tetrahydroxy-10-hydroxymethyl-13-methyl-3-((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-hexadecahydro-cyclopentaaphenanthren-17-yl-5H-furan-2-one

4-(R)-1,5,11,14-Tetrahydroxy-10-hydroxymethyl-13-methyl-3-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-hexadecahydro-cyclopentaaphenanthren-17-yl-5H-furan-2-one

4-1,5,11,14-Tetrahydroxy-10-hydroxymethyl-13-methyl-3-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-hexadecahydro-cyclopentaaphenanthren-17-yl-5H-furan-2-one

4-1,5,11,14-Tetrahydroxy-10-hydroxymethyl-13-methyl-3-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-hexadecahydro-cyclopentaaphenanthren-17-yl-5H-furan-2-one(Ouabain)

Ouabain4-1,5,11,14-Tetrahydroxy-10-hydroxymethyl-13-methyl-3-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-hexadecahydro-cyclopentaaphenanthren-17-yl-5H-furan-2-one

  Experimental Data
 ouabain

Species Dose Unit Control(Avg days) Treatment(Avg days) Avg/Med Lifespan Change(%) Control(Max days) Treatment(Max days) Max Lifespan Change(%) Significant Strain Gender PubMed Avg/Med Lifespan Change tab
Caenorhabditis elegans 33.000000000000000 umol/L -1.000000000000000 NS N2 24134630 Inactive
  Experimental Data Visualization
 ouabain

  Statistics Data
 ouabain

Species Avg/Med Lifespan Change(%) Max Lifespan Change(%) Count Reference Count Data point
Caenorhabditis elegans -1.000000000000000 1 1
  Statistics Data Visualization
 ouabain